Pharmaceutical Executive April 13, 2021
New data comparing past vs. present experience with telemedicine during the pandemic uncovers insight on how patients, doctors, and payers view the market post-COVID.
In June 2020, Ipsos delivered market research that defined how COVID-19 was forcing pharmaceutical companies to adopt new physician interaction models. About a year into the pandemic, we wanted to see how different stakeholders are currently experiencing telemedicine and what the they believe the future holds for its use. This article presents some of those findings, co-sponsored by m360 Research, and based on interviews with a combined 2,500 healthcare providers (HCPs), patients, and payers.
Telemedicine usage as a proportion of weekly patient appointments is at nearly half of June 2020 levels. Psychiatrists are continuing to adopt...
Today's Sponsors
Today's Sponsor